Adastra Labs, die alte Gulfside ...
Seite 1 von 1
Neuester Beitrag: 25.10.21 12:55
|Eröffnet am:||13.08.20 20:34||von: bozkurt7||Anzahl Beiträge:||20|
|Neuester Beitrag:||25.10.21 12:55||von: bozkurt7||Leser gesamt:||10.167|
bozkurt7: Adastra Labs, die alte Gulfside ...
Chico79: Diese Woche
Chico79: Nach dem letzten
Woran das nur liegen mag.
Stef_an: Canadian Chamber of Commerce
Stef_an: Adastra Signs LOI to Acquire...
Adastra Signs LOI to Acquire Iconic Legacy Market Phyto Extractions Brands
September 18, 2020 / Uncategorized
LANGLEY, BC / ACCESSWIRE / September 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a Letter of Intent (“LOI”) for the acquisition of Phyto Extractions Brands (“Phyto Extractions”).
Adastra entered into an LOI on September 16, 2020 with a BC-based company for the acquisition of the Phyto Extractions set of cannabis concentrates brands. Under the terms of the LOI, Adastra and Phyto Extractions will negotiate the purchase of intellectual property and existing licensing agreements Phyto Extractions Brands has trademarked 21 design and wordmarks associated with their cannabis concentrates and two for CBD-related concentrates in Canada as well as submitted trademark protection in the U.S.
Phyto Extractions brands are licensed through an agreement with CannMart Labs Inc., a majority-owned subsidiary of Namaste Technologies Inc. CannMart Labs will continue to hold its exclusive license to use Phyto trademarks on certain cannabis products. Under the terms of the agreement, Adastra is the exclusive producer of all distillate products licensed under Phyto Extractions brands, and will also support the production of hydrocarbon concentrates released under the Phyto Extractions family of brands once equipment commissioning has been completed.
The LOI is non-binding and a due diligence period is currently underway which, if successful, will be followed by the negotiation of a definitive agreement for the acquisition of all of the assets of the private company. The terms (i.e. share consideration and/or cash) will be announced once the definitive agreement is signed.
“Phyto Extractions brands is one of the most recognizable Canadian concentrate brands from the legacy market and they were at the forefront of transition into the regulated market. With presence in BC, AB, MB, SK and ON, their brand awareness and demand is growing at a rapid rate. According to Phyto Extractions, sales have doubled over the past three months and sell-through is high, with over 35,000 0.5 gram vaporizing cartridges sold to provincial distributors and licensed retailers in the last 30 days across Canada. Tremendous brand-equity, consumer support and goodwill have clearly transitioned from the legacy to the regulated market. Incorporation and development of successful cannabis concentrate brands is an integral part of Adastra’s long-term strategy to ensure market-share and stronger margins.”- Andy Hale, CEO Adastra Labs.
Phyto Extractions brands were first re-launched in the regulated market with a 0.5 gram vaporizing cartridge SKU in December 2019. Additional vaporizing SKUs were added over recent months for a total of 10 vaporizing SKUs. Phyto Extractions is following up its vaporizing category product offerings with the introduction of some of the first hydrocarbon live resin SKUs and a unique High-Terpene Full Spectrum Extract (HTFSE) CO2 terp sauce SKU later in September 2020.
About Adastra Labs Holdings Ltd.
Adastra Labs Holdings Ltd. is a Langley, BC-based cannabis company with a co-located Health Canada Licensed Standard Processing Facility and Analytical Testing Laboratory. Adastra can produce cannabis extract through supercritical CO2 extraction and secondary distillation as well as conduct in-process quality testing. Such extracts can easily be incorporated into edibles, beverages, topicals, tinctures, vape cartridges and other products that will serve the Canadian medical and adult-use cannabis markets.
Brainzero: Ein LOI super
Einmal im Monat ein LOI. LOL
Chico79: Dem Helmut
Ebi52: Es gibt so viele
Nur durch Schaden lernt der Lemming, aber leider wachsen immer wieder neue nach!
deuteronomium: große Verluste
Kanada meiden, alles was daher kommt ob Bergbau oder andere. Finger weg.
Die liegen im Keller die Leichen. Vertrauen zu Kanada Aktien = Null.
Stef_an: Q3 Zahlen
Monday, December 14, 2020 7:00 AM
Share this article now
Topic: Company Update
LANGLEY, BC / ACCESSWIRE / December 14, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce its financial and operating results for the third quarter financial results for the period ended September 30, 2020.
Key Financial Highlights
Gross revenue increased year-over-year from $Nil in Q3 2019 to $1.25 million in Q3 2020
Quarter-over-quarter gross revenue increased 190% to $825 thousand in Q3 2020
Gross revenue was improved by the continuing relationship with CannMart Inc., combined with our biomass agreement with Pure Sunfarms which allows for a steady supply of quality input material.
Adastra ended the quarter with a total cash balance of $2.3 million
A non-brokered private placement for gross proceeds of $3.49 million was completed in Q3 2020
Cash outflows for capital expenditures in the quarter were $1.2 million, compared to $595 thousand in Q2 2020
Capital expenditures primarily consisted of the acquisition of an EV-Mass Cryo-Ethanol extractor system from Evolved Extraction Solutions
Capital expenditures for the remainder of fiscal 2020 are expected to consist of its hydrocarbon extraction expansion plan which will include the ETS MeP XT70 system from ExtractionTek Solutions.
Operating expenses, increased to $3.7 million from $553 thousand in Q2 2020, driven by an increase in share-based payments, professional fees and consulting, and advertising and promotion. These costs are as a result of the increased activity and implementation of Adastra's planned operation model in Q3 2020 and are expected to be more fully reflected in Q4 2020....
Chico79: Viel los ist hier im Thread ja nicht mehr,
Selbst das Unternehmen vermeldet so gut wie keine neuen Fortschritte.
bozkurt7: lebt sie also doch noch ?
Die Aktien werden unter dem neuen Namen und mit einer neuen CUSIP-Nummer am 1. September 2021 gehandelt.